DT
PT
Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds
search-icon-img
search-icon-img
Advertisement

Higher calcium levels may predict heart disease

  • fb
  • twitter
  • whatsapp
  • whatsapp
featured-img featured-img
Photo for representation only. Photo: Thinkstock
Advertisement

 New York

Advertisement

Specks of calcium in the heart's artery walls could signal early risk of cardiovascular disease, particularly in men from South Asian countries, including India, and may help develop treatment methods, researchers say.

Advertisement

According to the team from the University of California-San Francisco (UCSF), people from South Asia are known to have a high chance of developing cardiovascular disease.

They may also develop risk factors such as high blood pressure, cholesterol and diabetes at a younger age. However, it remains unclear which clinical factors could help determine those at highest risk.

Advertisement

Further, South Asian men (8.8 per cent) were found to have a higher rate of calcification than their women (3.6 per cent) counterparts.

"The presence and change of coronary artery calcium may be useful for risk prediction in this ethnic population and may better guide the judicious use of statin and other preventive therapies," said lead author Alka Kanaya, Professor at UCSF.

The Journal of the American Heart Association (JAHA), the team focussed on nearly 700 patients with ethnic backgrounds from India, Pakistan, Bangladesh, Sri Lanka, Nepal and Bhutan and found that South Asian men had the same high rates of change in calcification of their artery walls over a five-year period as white men.

Coronary artery calcification (CAC) is the buildup of calcium in the arteries which can cause blood vessels to narrow and lead to the development of heart disease.

Early signs of CAC can be detected through a computed tomography (CT) scan. 

The American Heart Association recently recommended CAC testing in individuals with intermediate heart disease risk to help determine whether they should be treated with cholesterol-lowering medications. — IANS

Advertisement
Advertisement
Advertisement
tlbr_img1 Classifieds tlbr_img2 Videos tlbr_img3 Premium tlbr_img4 E-Paper tlbr_img5 Shorts